![Foto de Begoña](/img/nophoto.png)
Begoña
Graña Suárez
Publicacións (45) Publicacións de Begoña Graña Suárez
2024
-
Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer
JAMA network open, Vol. 7, Núm. 4, pp. e247811
-
SEOM-GEMCAD-TTD clinical guidelines for the adjuvant treatment of colon cancer (2023)
Clinical and Translational Oncology
2023
-
A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients
Biomedicine and Pharmacotherapy, Vol. 159
-
Ibero-American Consensus Review and Incorporation of New Biomarkers for Clinical Practice in Colorectal Cancer
Cancers, Vol. 15, Núm. 17
-
SEOM clinical guideline on heritable TP53-related cancer syndrome (2022)
Clinical and Translational Oncology, Vol. 25, Núm. 9, pp. 2627-2633
2022
-
Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial
British Journal of Cancer, Vol. 126, Núm. 6, pp. 874-880
-
Monitoring of RAS mutant clones in plasma of patients with RAS mutant metastatic colorectal cancer
Clinical and Translational Oncology, Vol. 24, Núm. 6, pp. 1209-1214
2021
-
Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain
BMC Cancer, Vol. 21, Núm. 1
-
Immunology and immunotherapy in CRC
Foundations of Colorectal Cancer (Elsevier), pp. 435-453
-
Recomendaciones de uso adecuado de pruebas y suplementos de vitamina D en población general
Conselleria de Sanidade
2020
-
Heat shock protein 90 chaperone regulates the E3 ubiquitin-ligase hakai protein stability
Cancers, Vol. 12, Núm. 1
-
Immunology and immunotherapy of colorectal cancer
Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (Springer), pp. 261-289
-
Regulation of epithelial-mesenchymal plasticity by the E3 ubiquitin-ligases in cancer
Cancers, Vol. 12, Núm. 11, pp. 1-24
-
SEOM clinical guidelines in hereditary breast and ovarian cancer (2019)
Clinical and Translational Oncology, Vol. 22, Núm. 2, pp. 193-200
2019
-
Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers
Cancer Medicine, Vol. 8, Núm. 3, pp. 882-889
-
SEOM clinical guidelines to primary prevention of cancer (2018)
Clinical and Translational Oncology, Vol. 21, Núm. 1, pp. 106-113
2018
-
Hakai overexpression effectively induces tumour progression and metastasis in vivo
Scientific Reports, Vol. 8, Núm. 1
-
Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain
Psycho-Oncology, Vol. 27, Núm. 6, pp. 1530-1537
2016
-
Screening for Lynch syndrome among patients with newly diagnosed endometrial cancer: A comprehensive review
Tumori, Vol. 102, Núm. 6, pp. 548-554
2015
-
El cáncer hereditario en mujeres
Arbor: Ciencia, pensamiento y cultura, Núm. 773